Literature DB >> 16434530

The use of the Ilizarov method as a salvage procedure in infected nonunion of the distal femur with bone loss.

A Saridis1, E Panagiotopoulos, M Tyllianakis, C Matzaroglou, N Vandoros, E Lambiris.   

Abstract

We reviewed 13 patients with infected nonunion of the distal femur and bone loss, who had been treated by radical surgical debridement and the application of an Ilizarov external fixator. All had severely restricted movement of the knee and a mean of 3.1 previous operations. The mean length of the bony defect was 8.3 cm and no patient was able to bear weight. The mean external fixation time was 309.8 days. According to Paley's grading system, eight patients had an excellent clinical and radiological result and seven excellent and good functional results. Bony union, the ability to bear weight fully, and resolution of the infection were achieved in all the patients. The external fixation time was increased when the definitive treatment started six months or more after the initial trauma, the patient had been subjected to more than four previous operations and the initial operation had been open reduction and internal fixation.

Entities:  

Mesh:

Year:  2006        PMID: 16434530     DOI: 10.1302/0301-620X.88B2.16976

Source DB:  PubMed          Journal:  J Bone Joint Surg Br        ISSN: 0301-620X


  22 in total

1.  Clinical outcomes with the corticotomy-first technique associated with the Ilizarov method for the management of the septic long bones non-union.

Authors:  Gamal Ahmed Hosny; Abdel-Salam Abdel-Aleem Ahmed; Mohamed Abd-Elaal Hussein
Journal:  Int Orthop       Date:  2018-04-07       Impact factor: 3.075

2.  Nonunions around the knee joint.

Authors:  Daniel B Chan; Devon M Jeffcoat; Dean G Lorich; David L Helfet
Journal:  Int Orthop       Date:  2009-12-12       Impact factor: 3.075

3.  Reconstruction of post-traumatic long segment bone defects of the lower end of the femur by free vascularized fibula combined with allograft (modified Capanna's technique).

Authors:  H Venkatramani; S R Sabapathy; J Dheenadayalan; A Devendra; S Rajasekaran
Journal:  Eur J Trauma Emerg Surg       Date:  2014-09-23       Impact factor: 3.693

4.  Local transplantation of bone marrow concentrated granulocytes precursors can cure without antibiotics infected nonunion of polytraumatic patients in absence of bone defect.

Authors:  Philippe Hernigou; Matthieu Trousselier; François Roubineau; Charlie Bouthors; Nathalie Chevallier; Helene Rouard; Charles Henri Flouzat-Lachaniette
Journal:  Int Orthop       Date:  2016-03-01       Impact factor: 3.075

5.  Treatment outcomes for infected juxta-articular knee nonunions.

Authors:  A Lagaras; V Kontogeorgakos; S Varitimidis; K N Malizos
Journal:  Hippokratia       Date:  2018 Oct-Dec       Impact factor: 0.471

6.  Comminuted distal femur closed fractures: a new application of the Ilizarov concept of compression-distraction.

Authors:  Ahmad El-Tantawy; Ashraf Atef
Journal:  Eur J Orthop Surg Traumatol       Date:  2014-11-27

7.  Distraction osteogenesis technique using an intramedullary nail and a monolateral external fixator in the reconstruction of massive postosteomyelitis skeletal defects of the femur.

Authors:  Zhihong Li; Xiangsheng Zhang; Liqun Duan; Xiaoming Chen
Journal:  Can J Surg       Date:  2009-04       Impact factor: 2.089

8.  A treatment for large defects of the tibia caused by infected nonunion: Ilizarov method with bone segment extension.

Authors:  K Xu; X Fu; Y-M Li; C-G Wang; Z-J Li
Journal:  Ir J Med Sci       Date:  2013-10-29       Impact factor: 1.568

9.  Periarticular large bone defects treatment with ring external fixator.

Authors:  Thanase Ariyawatkul; Kamolporn Kaewpornsawan; Perajit Eamsobhana
Journal:  J Clin Orthop Trauma       Date:  2018-04-24

10.  Primary ilizarov external fixation in open grade III type C distal femur fractures: Our experience.

Authors:  Rakesh Kumar; Soumya Shrikanta Mohapatra; Narendra Joshi; S K Goyal; Kamlesh Kumar; Rajendra Gora
Journal:  J Clin Orthop Trauma       Date:  2019-01-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.